TFR Capital
PFE icon

TFR Capital’s Pfizer PFE Stock Holding History

TFR Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$201K Buy
+7,054
New +$188K 0.05% 167

Other funds holding PFE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

TFR Capital's PFE Position: Q3 2026 in Review

TFR Capital opened a new position in Pfizer (PFE) in Q3 2026: 7,054 shares worth $201K. The stake represents 0.05% of the portfolio and ranks #167 among its holdings.

2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • TFR Capital held 7,054 shares of Pfizer worth $201K as of Q3 2026.
  • Pfizer was a new TFR Capital position in Q3 2026.
  • Pfizer made up 0.05% of TFR Capital's portfolio in Q3 2026, its #167 holding.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on TFR Capital's 13F filing for Q3 2026, filed 9 Nov 2026.